ChemoCentryx Announces Financial Results for the Quarter Ended September 30, 2012

[at noodls] – Company Provides Updates on the Development Plan for Its Lead Independent Development Program Focused on CCR2 Inhibitors MOUNTAIN VIEW, Calif., Nov. 13, 2012 (GLOBE NEWSWIRE) — ChemoCentryx, Inc. (Nasdaq:CCXI) … more

View todays social media effects on CCXI

View the latest stocks trending across Twitter. Click to view dashboard